HIV-1 Viral Dynamics in Subjects Initiating Raltegravir Therapy in Spain

NCT00685191 Phase 4 COMPLETED

The study purpose is to investigate plasma HIV-1 RNA dynamics in subjects initiating raltegravir-based salvage therapy and quantify the corresponding changes in levels of cellular HIV-1 DNA.

Details

Lead sponsor	Germans Trias i Pujol Hospital
Phase	Phase 4
Status	COMPLETED
Enrolment	15
Start date	2008-06
Completion	2009-10

Conditions

• HIV Infections

Interventions

• Salvage antiretroviral therapy including raltegravir

Primary outcomes

• Change in viral load from day 0 to 7 — 1 week

Countries

Spain